Grief intertwines with holiday traditions, creating a complex emotional landscape where joy and sorrow coexist, reflecting the depth of love and loss. The natural human process of grief is intensified ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Voranigo (vorasidenib), a drug for certain brain tumors, was safe and well toleratedin patients with grade 3 or 4 IDH-mutant ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

In observation of Neuroendocrine Tumors (NETs) Awareness Month, Dr. Pamela L. Kunz sat down for an interview with CURE to ...

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and manage talquetamab side effects, with prior experience from CAR-T therapy ...

Panelists discuss how healthcare providers must actively educate local oncologists, emergency departments, and community centers about bispecific antibody management as these therapies move from ...

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, comprehensive caregiver preparation including education materials and emergency ...

Panelists discuss how expectations for treatment outcomes can become more positive over time through experience with multiple therapies, staying informed about clinical trials and new treatments, and ...

Dr. Pamela L. Kunz sat down for an interview with CURE to discuss resources and ongoing initiatives that may help patients with this disease.

Panelists discuss how caregivers can navigate the initial shock of a myeloma diagnosis by seeking reliable information from trusted medical websites, connecting with local support groups, and ...